Updates related to OA, sent to Twitter during July 2009:
Archive for July, 2009
An essay by Jean-Claude Guédon, Open Access and the divide between “mainstream” and “peripheral” science, was posted recently (July 23, 2009) at Mesa Redonda sobre Patrimonio Intelectual y Conocimiento Libre. [Apparently, this is a website supported by the Government of Venezuela - Google translation from Spanish to English: "Roundtable on Intellectual Heritage and Free Knowledge"]. A short excerpt from the latter part of this interesting essay:
This paper identifies the facets of the Gold and Green Roads that make sense in addressing the scandal of the knowledge divide. It brings to light essentially two fundamental strategies: on the Gold side, fully subsidized journals that do not financially penalize authors from poor countries, or do not submit them to humiliating forms of pleading for special treatment are essential. On the Green side of Open Access, the way to create symbolic value in competition with what presently supports the divide barriers is to organize a coherent system of institutional and thematic repositories. The former are charged with collecting and preserving all that they can and want to preserve. It is through institutional repositories that depositing mandates should be implemented as mandates can originate from a variety of institutions with some political clout, universities, research centres and granting agencies among them. However, it is through thematic repositories that the (research) wheat can be separated from the chaff and it is through them that various forms of new and useful forms of symbolic value can be created.
This essay had been deposited previously, as an eprint of a book chapter, in the E-LIS repository. The eprint was last modified on November 19, 2008. The citation indicates that this book chapter was expected to be “forthcoming in 2007, in Portuguese“.
Blog items (apparently, about an earlier version of the eprint) were posted by Peter Suber (OA for mainstreaming peripheral science) on December 1, 2007 and by Heather Morrison (National open access journal subsidy) on December 1, 2007. The eprint has been cited on CiteULike, and a version is also available via Scribd, posted on August 18, 2008 (see: http://bit.ly/coRCx).
The version posted at the Venezuelan site has generated some recent interest on FriendFeed. See, for example, http://ff.im/5If9y (July 25, by Bill Hooker) and http://ff.im/5NDNw (July 27, by Bora Zivkovic). Recommendation from Bora Zivkovic: “[Essay] by Jean-Claude Guédon is a Must Read of the day“.
Comment: An excerpt from Heather Morrison’s blog post is noteworthy:
Scielo is an excellent example of what can be accomplished through a nationally subsidized open access program. While the Scielo portal encompasses the scholarly work of many latin countries, Brazil alone, in 2005, brought 160 fully open access journals to the world at a very modest cost of only $1 million dollars.
Canada is experimenting with subsidized open access journals, through the Aid to Open Access Journals program.
Note: The link to the webpage for SSHRC’s Aid to Open Access Journals program has been updated in the excerpt. This program has been renamed the SSHRC Aid to Scholarly Journals program. See also: About SSHC > Policy Focus > Open Access.
Excerpt from the home page: Cellular Therapy and Transplantation is a new international, peer-reviewed, open access journal which publishes articles in the fields of cellular and genetic therapy and transplantation.
1. Are there any article charges?
For the first five issues, authors can publish in CTT without any article charges.
7. Author license
The CTT author license says that copyright is retained by you, the authors, and that by sending us your final version you confirm that no rights of third parties have been infringed on. We recommend you choose a Creative Commons license to go with your article. …..
The first issue (Vol. 1, No. 1, June 2008) includes a foreword by Mikhail Gorbachev.
New Web site launches $1.7 million project to improve European cancer communications, EurekAlert, July 19, 2009. Excerpt:
The Eurocancercoms project is an initiative of the European Institute of Oncology and is led by ECCO – the European CanCer Organisation and ecancermedicalscience (an online, open access journal).
Comment: The OA journal ecancermedicalscience has published three volumes, one for each of 2007 (7 articles), 2008 (34 articles) and 2009 (16 articles, so far). Free registration is required to view the full text of an article. About the journal: “It is free to publish your paper, it is free to register and read – and you’re free to comment online, on the science, the editorials, the policy papers or the case reports“. The journal uses the name ecancer on Twitter. A FriendFeed search for ecancer (on July 24, 2009) yielded tweets from http://twitter.com/ecancer dated March 4, 2009 or later. Tweets dated February 23, 1009 or later were available (again, on July 24, 2009) from the ecancer site itself. I have not yet found a way to archive links to individual tweets.
Nature vs. Science, pt. 2, PHD Comics, July 17, 2009. From the third panel: “It [supporting the business of Nature] sounds outrageous, but scientists will do it, because they want to be published“. The second panel provides a concise summary, in cartoon format, of the toll-access business model.
Comment: Found via a FriendFeed entry from Bora Zivkovic (Coturnix). Updates about PHD Comics (by Jorge Cham) are available from phdcomics via Twitter. Nature vs. Science, pt. 1 and PHD Comics, from 1997 onwards, are available from the archive. A Blogs search for mention of PHD Comics on Nature Networks (on July 20, 2009) yielded 5 results. One of these is Yes, Timo, we do! by Heather Etchevers, July 20, 2009. Excerpts:
The second panel might seem amusing or cynical, depending on your point of view, but it is realistic. …..
The third panel is a bit facile. Scientists “do it” because they want to be published in one of these two journals in particular.
The Twitter Journal of Nanoscience is a new informal service, not a peer review journal. Excerpt from its webpage:
TTJN aims to be an informal, central point for collection of interesting information and updates from scientists on the front-line of Nanoscience research and spreading this information, 140 characters at a time to its audience on Twitter. Articles can be on interesting observations from the laboratory, a picture of something you’ve seen through a microscope, letting people know about your ASAP article in a journal, anything really, we’ll leave it up to you and see how it grows over time